Yuyu Pharma Inc (000225) — Capital Reinvestment Ratio
Latest as of March 2026:
1.08x
Yuyu Pharma Inc (000225) has a Capital Reinvestment Ratio of 1.08x as of March 2026, meaning it reinvests 1% of its operating cash flow (₩2.95 Billion) in capital expenditures (₩3.19 Billion). See how much free cash does Yuyu Pharma Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.08x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.95 Billion
KRW
Capital Expenditures
₩3.19 Billion
KRW
Data as of
Mar 2026
Most recent filing
Yuyu Pharma Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Yuyu Pharma Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma Inc from 2014 to 2025. For live market cap and broader valuation context, see 000225 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | ₩15.88 Billion | ₩8.45 Billion | ▲ +81.9% |
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow